Clinical Trials Logo

Elevated Intraocular Pressure clinical trials

View clinical trials related to Elevated Intraocular Pressure.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT05165290 Active, not recruiting - Clinical trials for Elevated Intraocular Pressure

Prospective, Double-masked, Randomized, Multi-center, Active-controlled, Parallel-group, 3-month Study Assessing the Safety & Ocular Hypotensive Efficacy of TC-002 Ophthalmic Solution Compared to Latanoprost Ophthalmic Solution 0.005% in Subjects With Elevated Intraocular Pressure

TC-002-301
Start date: November 29, 2021
Phase: Phase 3
Study type: Interventional

Prospective, double-masked, randomized, multi-center, active-controlled, parallel-group, 3-month study assessing the safety and ocular hypotensive efficacy of TearClear latanoprost Ophthalmic Solution, 0.005% (TC-002) compared to latanoprost Ophthalmic Solution, 0.005% (LAT) in subjects with elevated intraocular pressure at approximately 20 study sites located in the United States